Medicine:Pathogenic bacteria
| Pathogenic bacteria | |
|---|---|
| Neisseria gonorrhoeae (small red dots) in pus from a man with a urethral discharge (Gram stain) |
Pathogenic bacteria are bacteria that can cause disease.[1] This article focuses on the bacteria that are pathogenic to humans. Most species of bacteria are harmless and many are beneficial but others can cause infectious diseases. The number of these pathogenic species in humans is estimated to be fewer than a hundred.[2] By contrast, several thousand species are considered part of the gut flora, with a few hundred species present in each individual human's digestive tract.[3]
The body is continually exposed to many species of bacteria, including beneficial commensals, which grow on the skin and mucous membranes, and saprophytes, which grow mainly in the soil and in decaying matter. The blood and tissue fluids contain nutrients sufficient to sustain the growth of many bacteria. The body has defence mechanisms that enable it to resist microbial invasion of its tissues and give it a natural immunity or innate resistance against many microorganisms.
Pathogenic bacteria are specially adapted and endowed with mechanisms for overcoming the normal body defences, and can invade parts of the body, such as the blood, where bacteria are not normally found. Some pathogens invade only the surface epithelium, skin or mucous membrane, but many travel more deeply, spreading through the tissues and disseminating by the lymphatic and blood streams. In some rare cases a pathogenic microbe can infect an entirely healthy person, but infection usually occurs only if the body's defence mechanisms are damaged by some local trauma or an underlying debilitating disease, such as wounding, intoxication, chilling, fatigue, and malnutrition. In many cases, it is important to differentiate infection and colonization, which is when the bacteria are causing little or no harm.

Caused by Mycobacterium tuberculosis bacteria, one of the diseases with the highest disease burden is tuberculosis, which killed 1.4 million people in 2019, mostly in sub-Saharan Africa.[5] Pathogenic bacteria contribute to other globally important diseases, such as pneumonia, which can be caused by bacteria such as Staphylococcus, Streptococcus and Pseudomonas, and foodborne illnesses, which can be caused by bacteria such as Shigella, Campylobacter, and Salmonella. Pathogenic bacteria also cause infections such as tetanus, typhoid fever, diphtheria, syphilis, and leprosy.
Pathogenic bacteria are also the cause of high infant mortality rates in developing countries.[6] A GBD study estimated the global death rates from (33) bacterial pathogens, finding such infections contributed to one in 8 deaths (or ~7.7 million deaths), which could make it the second largest cause of death globally in 2019.[7][4]
Most pathogenic bacteria can be grown in cultures and identified by Gram stain and other methods. Bacteria grown in this way are often tested to find which antibiotics will be an effective treatment for the infection. For hitherto unknown pathogens, Koch's postulates are the standard to establish a causative relationship between a microbe and a disease.
Diseases

Each species has specific effect and causes symptoms in people who are infected. Some people who are infected with a pathogenic bacteria do not have symptoms. Immunocompromised individuals are more susceptible to pathogenic bacteria.[8]
Pathogenic susceptibility
Some pathogenic bacteria cause disease under certain conditions, such as entry through the skin via a cut, through sexual activity or through compromised immune function.[9][10]

Some species of Streptococcus and Staphylococcus are part of the normal skin microbiota and typically reside on healthy skin or in the nasopharyngeal region. Yet these species can potentially initiate skin infections. Streptococcal infections include sepsis, pneumonia, and meningitis.[11] These infections can become serious creating a systemic inflammatory response resulting in massive vasodilation, shock, and death.[12]
Other bacteria are opportunistic pathogens and cause disease mainly in people with immunosuppression or cystic fibrosis. Examples of these opportunistic pathogens include Pseudomonas aeruginosa, Burkholderia cenocepacia, and Mycobacterium avium.[13][14]
Intracellular
Obligate intracellular parasites (e.g. Chlamydophila, Ehrlichia, Rickettsia) are only able to grow and replicate inside other cells.[15][16] Infections due to obligate intracellular bacteria may be asymptomatic, requiring an incubation period.[16] Examples of obligate intracellular bacteria include Rickettsia prowazekii (typhus) and Rickettsia rickettsii, (Rocky Mountain spotted fever).[17]
Chlamydia are intracellular parasites. These pathogens can cause pneumonia or urinary tract infection and may be involved in coronary heart disease.[18]
Other groups of intracellular bacterial pathogens include Salmonella, Neisseria, Brucella, Mycobacterium, Nocardia, Listeria, Francisella, Legionella, and Yersinia pestis. These can exist intracellularly, but can exist outside host cells.[19]
Infections in specific tissue
Bacterial pathogens often cause infection in specific areas of the body. Others are generalists.
- Bacterial vaginosis is a condition of the vaginal microbiota in which an excessive growth of Gardnerella vaginalis and other mostly anaerobic bacteria displace the beneficial Lactobacilli species that maintain healthy vaginal microbial populations.[20]
- Bacterial meningitis is a bacterial inflammation of the meninges, which are the protective membranes covering the brain and spinal cord.
- Bacterial pneumonia is a bacterial infection of the lungs.
- Urinary tract infection is predominantly caused by bacteria. Symptoms include the strong and frequent sensation or urge to urinate, pain during urination, and urine that is cloudy.[21] The most frequent cause is Escherichia coli. Urine is typically sterile but contains a variety of salts and waste products. Bacteria can ascend into the bladder or kidney and causing cystitis and nephritis.[22][23]
- Bacterial gastroenteritis is caused by enteric, pathogenic bacteria. These pathogenic species are usually distinct from the usually harmless bacteria of the normal gut flora. But a different strain of the same species may be pathogenic. The distinction is sometimes difficult as in the case of Escherichia.
- Bacterial skin infections include:
- Impetigo is a highly contagious bacterial skin infection commonly seen in children.[24] It is caused by Staphylococcus aureus, and Streptococcus pyogenes.[25]
- Erysipelas is an acute streptococcus bacterial infection[26] of the deeper skin layers that spreads via with lymphatic system.
- Cellulitis is a diffuse inflammation[27] of connective tissue with severe inflammation of dermal and subcutaneous layers of the skin. Cellulitis can be caused by normal skin flora or by contagious contact, and usually occurs through open skin, cuts, blisters, cracks in the skin, insect bites, animal bites, burns, surgical wounds, intravenous drug injection, or sites of intravenous catheter insertion. In most cases it is the skin on the face or lower legs that is affected, though cellulitis can occur in other tissues.
Mechanisms of damage
The symptoms of disease appear as pathogenic bacteria damage host tissues or interfere with their function. The bacteria can damage host cells directly or indirectly by provoking an immune response that inadvertently damages host cells,[28] or by releasing toxins.[29]
Direct
Once pathogens attach to host cells, they can cause direct damage as the pathogens use the host cell for nutrients and produce waste products.[30] For example, Streptococcus mutans, a component of dental plaque, metabolizes dietary sugar and produces acid as a waste product. The acid decalcifies the tooth surface to cause dental caries.[31]
Toxin production

Endotoxins are the lipid portions of lipopolysaccharides that are part of the outer membrane of the cell wall of gram-negative bacteria. Endotoxins are released when the bacteria lyses, which is why after antibiotic treatment, symptoms can worsen at first as the bacteria are killed and they release their endotoxins. Exotoxins are secreted into the surrounding medium or released when the bacteria die and the cell wall breaks apart.[32]
Indirect
An excessive or inappropriate immune response triggered by an infection may damage host cells.[1]
Survival in host
Nutrients
Iron is required for humans, as well as the growth of most bacteria. To obtain free iron, some pathogens secrete proteins called siderophores, which take the iron away from iron-transport proteins by binding to the iron even more tightly. Once the iron-siderophore complex is formed, it is taken up by siderophore receptors on the bacterial surface and then that iron is brought into the bacterium.[32]
Bacterial pathogens also require access to carbon and energy sources for growth. To avoid competition with host cells for glucose which is the main energy source used by human cells, many pathogens including the respiratory pathogen Haemophilus influenzae specialise in using other carbon sources such as lactate that are abundant in the human body [33]
Identification

Typically identification is done by growing the organism in a wide range of cultures which can take up to 48 hours. The growth is then visually or genomically identified. The cultured organism is then subjected to various assays to observe reactions to help further identify species and strain.[34]
Treatment
Bacterial infections may be treated with antibiotics, which are classified as bacteriocidal if they kill bacteria or bacteriostatic if they just prevent bacterial growth. There are many types of antibiotics and each class inhibits a process that is different in the pathogen from that found in the host. For example, the antibiotics chloramphenicol and tetracyclin inhibit the bacterial ribosome but not the structurally different eukaryotic ribosome, so they exhibit selective toxicity.[35] Antibiotics are used both in treating human disease and in intensive farming to promote animal growth. Both uses may be contributing to the rapid development of antibiotic resistance in bacterial populations.[36] Phage therapy, using bacteriophages can also be used to treat certain bacterial infections.[37]
Prevention
Infections can be prevented by antiseptic measures such as sterilizing the skin prior to piercing it with the needle of a syringe and by proper care of indwelling catheters. Surgical and dental instruments are also sterilized to prevent infection by bacteria.[38] Disinfectants such as bleach are used to kill bacteria or other pathogens on surfaces to prevent contamination and further reduce the risk of infection.[39] Bacteria in food are killed by cooking to temperatures above 73 °C (163 °F).[40]
List of genera and microscopy features
Many genera contain pathogenic bacterial species. They often possess characteristics that help to classify and organize them into groups. The following is a partial listing.
| Genus | Species | Gram staining | Shape | Oxygen requirement | Intra/Extracellular |
|---|---|---|---|---|---|
| Bacillus[41] | Positive | Rods | Facultative anaerobic | Extracellular | |
| Bartonella[41] | Negative | Rods | Aerobic | Facultative intracellular | |
| Bordetella[41] | Negative | Small coccobacilli | Aerobic | Extracellular | |
| Borrelia[41] | Negative, stains poorly | Spirochete | Anaerobic | Extracellular | |
| Brucella[41] | Negative | Coccobacilli | Aerobic | Intracellular | |
| Campylobacter[41] | Negative | Spiral rods[44] coccoid in older cultures[44] |
Microaerophilic[44] | Extracellular | |
| Chlamydia and Chlamydophila[41] |
|
(not Gram-stained) | Small, round, ovoid | Facultative or strictly aerobic | Obligate intracellular |
| Clostridium[41] | Positive | Large, blunt-ended rods | Obligate anaerobic | Extracellular | |
| Corynebacterium[41] | Positive (unevenly) | Rods | Mostly facultative anaerobic | Extracellular | |
| Enterococcus[43][47] | Positive | Cocci | Facultative Anaerobic | Extracellular | |
| Escherichia[6][43][48] | Negative | Rods | Facultative anaerobic | Extracellular or Intracellular | |
| Francisella[41] | Negative | Coccobacillus | Strictly aerobic | Facultative intracellular | |
| Haemophilus | Negative | Coccobacilli to long and slender filaments | Facultative anaerobic 5 – 10% CO2 | Extracellular | |
| Helicobacter | Negative | Spiral rod | Microaerophile | Extracellular | |
| Legionella[41] | Negative, stains poorly | Cocobacilli | Aerobic | Facultative intracellular | |
| Leptospira[43][51] | Negative, stains poorly | Spirochete | Strictly aerobic | Extracellular | |
| Listeria[41] | Positive, darkly | Slender, short rods | Facultative Anaerobic | Facultative intracellular | |
| Mycobacterium[41] | (none) | Long, slender rods | Aerobic | Intracellular | |
| Mycoplasma[41] | (none) | Indistinct 'fried egg' appearance, no cell wall | Mostly facultative anaerobic; M. pneumoniae strictly aerobic | Extracellular | |
| Neisseria[43][52] | Negative | Kidney bean-shaped | Aerobic | Gonococcus: facultative intracellular N. meningitidis: extracellular | |
| Pseudomonas[43][53] | Negative | Rods | Obligate aerobic | Extracellular | |
| Rickettsia[41] | Negative, stains poorly | Small, rod-like coccobacillary | Aerobic | Obligate intracellular | |
| Salmonella[41] |
|
Negative | Rods | Facultative anaerobic | Facultative intracellular |
| Shigella[43][54] | Negative | Rods | Facultative anaerobic | Extracellular | |
| Staphylococcus[6] | Positive, darkly | Round cocci | Facultative anaerobic | Extracellular, facultative intracellular | |
| Streptococcus[41] | Positive | Ovoid to spherical | Facultative anaerobic | Extracellular | |
| Treponema[41] | Negative, stains poorly | Spirochete | Aerobic | Extracellular | |
| Ureaplasma[6] | Stains poorly[55] | Indistinct, 'fried egg' appearance, no cell wall | Anaerobic | Extracellular | |
| Vibrio[43][56] | Negative | Spiral with single polar flagellum | Facultative anaerobic | Extracellular | |
| Yersinia[43][57] | Negative, bipolarly | Small rods | Facultative anaerobe | Intracellular |
List of species and clinical characteristics
-
Overall age-standardised mortality rate per 100 000 population for 33 pathogens investigated, 2019[4]
-
Global number of deaths (A) and YLLs (B), by pathogen and infectious syndrome, 2019[4]
-
Global number of deaths, by pathogen, age, and sex groups, 2019[4]
This is description of the more common genera and species presented with their clinical characteristics and treatments.
| Species | Transmission | Diseases | Treatment | Prevention | ||
|---|---|---|---|---|---|---|
| Actinomyces israelii | Oral flora[58] | Actinomycosis:[58] painful abscesses and cysts MRSA in the mouth, lungs,[59][60] or gastrointestinal tract.[45] | Prolonged penicillin G and drainage[58] | |||
| Bacillus anthracis |
Contact with cattle, sheep, goats and horses[61] |
Anthrax: pulmonary, gastrointestinal and/or cutaneous symptoms.[58] |
In early infection:[62] |
Anthrax vaccine[43] | ||
| Bacteroides fragilis | Gut flora[58] | Abscesses in gastrointestinal tract, pelvic cavity and lungs[58] | Metronidazole[58] | Wound care[64] | ||
| Bordetella pertussis |
Contact with respiratory droplets expelled by infected human hosts.[43] |
Macrolides[43] such as erythromycin,[43][58] before paroxysmal stage[58] |
Pertussis vaccine,[43][58] such as in DPT vaccine[43][58] | |||
| Borrelia | B. burgdorferi[43][58] |
Ixodes hard ticks |
|
Doxycycline for adults, amoxicillin for children, ceftriaxone for neurological involvement[66] |
Wearing clothing that limits skin exposure to ticks.[43] | |
| B. recurrentis[68] and others[note 1] |
Pediculus humanus corporis body louse (B. recurrentis only) and Ornithodoros soft ticks[68] | Relapsing fever | Penicillin, tetracycline, doxycycline[69] | Avoid areas where ticks are found[68] Better access to washing facilities[68] | ||
| Brucella | B. abortus |
Direct contact with infected animal[43] |
Brucellosis: mainly fever, muscular pain and night sweats |
|||
| Campylobacter jejuni |
Fecal–oral from animals (mammals and fowl)[43][58] |
|
Treat symptoms[43] |
Good hygiene[43] | ||
| Chlamydia | C. pneumoniae | Atypical pneumonia[58] | None[43] | |||
| C. trachomatis |
vaginal sex[43] |
Trachoma[43][58] |
Erythromycin[43][58] |
Erythromycin or silver nitrate in newborn's eyes[43] | ||
| Chlamydophila psittaci | Inhalation of dust with secretions or feces from birds (e.g. parrots) | Psittacosis, mainly atypical pneumonia | - | |||
| Clostridium | C. botulinum | Spores from soil,[43][58] persevere in canned food, smoked fish and honey[58] |
Botulism: Mainly muscle weakness and paralysis[58] |
Antitoxin[43][58] |
Proper food preservation techniques | |
| C. difficile |
Gut flora,[43][58] overgrowing when other flora is depleted[43] |
Discontinuing responsible antibiotic[43][58] |
Fecal bacteriotherapy | |||
| C. perfringens |
Spores in soil[43][58] |
Anaerobic cellulitis[43][58] |
Gas gangrene:
Debridement or amputation[43][58] |
Appropriate food handling[43] | ||
| C. tetani |
Tetanus immune globulin[43][58]
Sedatives[43] |
Tetanus vaccine (such as in the DPT vaccine)[43] | ||||
| Corynebacterium diphtheriae |
respiratory droplets |
Diphtheria: Fever, sore throat and neck swelling, potentially narrowing airways.[71] |
Horse serum antitoxin |
|||
| Ehrlichia | E. canis[58] |
Dog tick[58] | Ehrlichiosis:[58] headache, muscle aches, and fatigue |
|
||
| Enterococcus | E. faecalis |
Part of gut flora,[58] opportunistic or entering through GI tract or urinary system wounds[43] |
Bacterial endocarditis,[58] biliary tract infections,[58] urinary tract infections[58] |
Ampicillin (combined with aminoglycoside in endocarditis)[58] Vancomycin[43] |
No vaccine Hand washing and other nosocomial prevention | |
| Escherichia | E. coli (generally) | UTI:[43]
(resistance-tests are required first)
Meningitis:[43]
Diarrhea:[43]
|
(no vaccine or preventive drug)[43] | |||
| Enterotoxigenic E. coli (ETEC) |
|
|||||
| Enteropathogenic E. coli |
|
| ||||
| Enteroinvasive E.coli (EIEC) |
| |||||
| Enterohemorrhagic (EHEC), including E. coli O157:H7 |
|
|||||
| Francisella tularensis | Tularemia: Fever, ulceration at entry site and/or lymphadenopathy.[73] Can cause severe pneumonia.[73] | |||||
| Haemophilus influenzae |
|
Meningitis:[43]
(resistance-tests are required first)
|
| |||
| Helicobacter pylori |
|
|
(No vaccine or preventive drug)[43] | |||
| Klebsiella pneumoniae |
|
|
|
|||
| Legionella pneumophila |
|
(no vaccine or preventive drug)[43]
Heating water[43] | ||||
| Leptospira species |
|
|
|
Vaccine not widely used[43]
Prevention of exposure[43]
| ||
| Listeria monocytogenes |
|
(no vaccine)[43]
| ||||
| Mycobacterium | M. leprae |
|
|
Tuberculoid form:
Lepromatous form: |
| |
| M. tuberculosis |
|
|
(Difficult, see Tuberculosis treatment for more details)[43] Standard "short" course:[43]
|
| ||
| Mycoplasma pneumoniae | ||||||
| Neisseria | N. gonorrhoeae |
|
Uncomplicated gonorrhea:[43]
Ophthalmia neonatorum: |
(No vaccine)[43]
| ||
| N. meningitidis |
|
|||||
| Pseudomonas aeruginosa | Opportunistic;[58] Infects damaged tissues or people with immunodeficiency.[43] | Pseudomonas infection:[43] |
|
(no vaccine)[43]
| ||
| Nocardia asteroides | In soil[58] | Nocardiosis:[58] Pneumonia, endocarditis, keratitis, neurological or lymphocutaneous infection | TMP/SMX[58] | |||
| Rickettsia rickettsii | (no preventive drug or approved vaccine)[43]
| |||||
| Salmonella | S typhi |
|
|
|
||
| Other Salmonella species
|
|
(No vaccine or preventive drug)[43] | ||||
| Shigella | S. sonnei[43] |
|
|
|||
| Staphylococcus | aureus | Coagulase-positive staphylococcal infections:
|
|
(no vaccine or preventive drug)
| ||
| epidermidis | Human flora in skin,[43][58] anterior nares[43] and mucous membranes[58] |
|
None[43] | |||
| saprophyticus | Part of normal vaginal flora[43] |
|
None[43] | |||
| Streptococcus | agalactiae | Human flora in vagina,[43][58] urethral mucous membranes,[43] rectum[43]
|
|
None[43] | ||
| pneumoniae |
|
|||||
| pyogenes |
|
|
No vaccine[43]
| |||
| viridans | Oral flora,[58] penetration through abrasions |
|
Penicillin G[58] | |||
| Treponema pallidum subspecies pallidum |
|
|||||
| Vibrio cholerae |
|
|
| |||
| Yersinia pestis | Plague: |
|
||||
Genetic transformation
See also
- Human microbiome project
- List of antibiotics
- Pathogenic viruses
Notes
- ↑ Relapsing fever can also be caused by the following Borrelia species: B. crocidurae, B. duttonii, B. hermsii, B. hispanica, B. miyamotoi, B. persica, B. turicatae and B. venezuelensis.
- Barbour, Alan G. (2017). "Relapsing Fever". in Kasper, Dennis L.; Fauci, Anthony S.. Harrison's Infectious Diseases (3rd ed.). New York: McGraw Hill Education. pp. 678–687. ISBN 978-1-259-83597-1.
References
- ↑ 1.0 1.1 Ryan, Kenneth J.; Ray, C. George; Ahmad, Nafees; Drew, W. Lawrence; Lagunoff, Michael; Pottinger, Paul; Reller, L. Barth; Sterling, Charles R. (2014). "Pathogenesis of Bacterial Infections". Sherris Medical Microbiology (6th ed.). New York: McGraw Hill Education. pp. 391–406. ISBN 978-0-07-181826-1.
- ↑ McFall-Ngai, Margaret (2007-01-11). "Adaptive Immunity: Care for the community" (in en). Nature 445 (7124): 153. doi:10.1038/445153a. ISSN 0028-0836. PMID 17215830. Bibcode: 2007Natur.445..153M.
- ↑ Leviatan, Sigal; Shoer, Saar; Rothschild, Daphna; Gorodetski, Maria; Segal, Eran (2022). "An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species". Nature Communications 13 (1): 3863. doi:10.1038/s41467-022-31502-1. PMID 35790781. Bibcode: 2022NatCo..13.3863L.
- ↑ 4.0 4.1 4.2 4.3 4.4 Ikuta, Kevin S.Expression error: Unrecognized word "et". (21 November 2022). "Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019" (in English). The Lancet 400 (10369): 2221–2248. doi:10.1016/S0140-6736(22)02185-7. ISSN 0140-6736. PMID 36423648. Bibcode: 2022Lanc..400.2221I.
- ↑ "Tuberculosis (TB)" (in en). https://www.who.int/en/news-room/fact-sheets/detail/tuberculosis.
- ↑ 6.0 6.1 6.2 6.3 Santosham, Mathuram; Chan, Grace J.; Lee, Anne CC; Baqui, Abdullah H.; Tan, Jingwen; Black, Robert E. (2013). "Risk of Early-Onset Neonatal Infection with Maternal Infection or Colonization: A Global Systematic Review and Meta-Analysis". PLOS Medicine 10 (8). doi:10.1371/journal.pmed.1001502. ISSN 1549-1676. PMID 23976885.
- ↑ Hou, Chia-Yi (23 November 2022). "Bacterial infections linked to 1 in 8 deaths in 2019". The Hill. https://thehill.com/changing-america/well-being/prevention-cures/3748033-bacterial-infections-linked-to-1-in-8-deaths-in-2019/.
- ↑ "Diagnosis of severe respiratory infections in immunocompromised patients". Intensive Care Medicine 46 (2): 298–314. February 2020. doi:10.1007/s00134-019-05906-5. PMID 32034433.
- ↑ Walker, D.H. (2014), "Interactions of Pathogens with the Host" (in en), Pathobiology of Human Disease, Elsevier, pp. 214–216, doi:10.1016/B978-0-12-386456-7.01701-9, ISBN 978-0-12-386457-4
- ↑ "14.2B: Opportunistic Microorganisms" (in en). 2018-06-26. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_(Boundless)/14%3A_Pathogenicity/14.02%3A_Overview_of_Microbe-Host_Interactions/14.2B%3A_Opportunistic_Microorganisms.
- ↑ "Streptococcal Infections - Infectious Diseases" (in en). https://www.msdmanuals.com/professional/infectious-diseases/gram-positive-cocci/streptococcal-infections.
- ↑ Fish DN (February 2002). "Optimal antimicrobial therapy for sepsis". Am J Health Syst Pharm 59 (Suppl 1): S13–9. doi:10.1093/ajhp/59.suppl_1.S13. PMID 11885408. http://www.ajhp.org/cgi/pmidlookup?view=long&pmid=11885408.
- ↑ Heise E (1982). "Diseases associated with immunosuppression". Environ Health Perspect 43: 9–19. doi:10.2307/3429162. PMID 7037390.
- ↑ Saiman L (2004). "Microbiology of early CF lung disease". Paediatr Respir Rev 5 (Suppl A): S367–9. doi:10.1016/S1526-0542(04)90065-6. PMID 14980298.
- ↑ Mandel, Cameron G.; Sanchez, Savannah E.; Monahan, Colleen C.; Phuklia, Weerawat; Omsland, Anders (2024). "Metabolism and physiology of pathogenic bacterial obligate intracellular parasites". Frontiers in Cellular and Infection Microbiology 14. doi:10.3389/fcimb.2024.1284701. ISSN 2235-2988. PMID 38585652.
- ↑ 16.0 16.1 Ölander, Magnus; Sixt, Barbara S. (July 2022). "Bringing genetics to heretofore intractable obligate intracellular bacterial pathogens: Chlamydia and beyond". PLOS Pathogens 18 (7). doi:10.1371/journal.ppat.1010669. ISSN 1553-7374. PMID 35901011.
- ↑ Shen, Chang-Hui (2023-01-01), "Chapter 16 - Molecular diagnosis of infectious diseases", Diagnostic Molecular Biology (Second Edition), Academic Press, pp. 457–490, doi:10.1016/B978-0-323-91788-9.00015-6, ISBN 978-0-323-91788-9, https://www.sciencedirect.com/science/article/pii/B9780323917889000156, retrieved 2026-07-11
- ↑ "Chlamydia pneumoniae and atherosclerosis". Cell Microbiol 6 (2): 117–27. 2004. doi:10.1046/j.1462-5822.2003.00352.x. PMID 14706098.
- ↑ Tankeshwar, Acharya (2013-05-20). "Extracellular and Intracellular Bacteria". https://microbeonline.com/extracellular-and-intracellular-bacteria-and-their-preferred-growth-phase-within-the-host/.
- ↑ "Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses". The Journal of Infectious Diseases 214 (Suppl 1): S1–5. August 2016. doi:10.1093/infdis/jiw121. PMID 27449868.
- ↑ "Urinary Tract Infections". MedicineNet. http://www.medicinenet.com/urine_infection/page4.htm.
- ↑ Roxe DM. Urinalysis. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 191. Available from: https://www.ncbi.nlm.nih.gov/books/NBK302/
- ↑ "The challenge of urinary tract infections in renal transplant recipients". Transplant Infectious Disease 20 (2). April 2018. doi:10.1111/tid.12828. PMID 29272071.
- ↑ "Impetigo". 19 October 2017. http://www.nhs.uk/conditions/Impetigo/Pages/Introduction.aspx. Page last reviewed: 17/07/2014
- ↑ Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; & Mitchell, Richard N. (2007). Robbins Basic Pathology (8th ed.). Saunders Elsevier. pp. 843 ISBN 978-1-4160-2973-1
- ↑ "erysipelas" at Dorland's Medical Dictionary
- ↑ "cellulitis" at Dorland's Medical Dictionary
- ↑ Greenwood, David; Barer, Mike; Slack, Richard; Irving, Will (2012). "Bacterial Pathogenicity". Medical Microbiology, a Guide to Microbial Infections: Pathogenesis, Immunity, Laboratory Investigation, and Control (18th ed.). Edinburgh: Churchill Livingstone. pp. 156–167. ISBN 978-0-7020-4089-4.
- ↑ "Bacterial toxins: Offensive, defensive, or something else altogether?". PLOS Pathogens 13 (9). September 2017. doi:10.1371/journal.ppat.1006452. PMID 28934339.
- ↑ Tortora, Gerald J.; Funke, Berdell R.; Case, Christine L. (2016). "Microbial Mechanisms of Pathogenicity". Microbiology, an Introduction (12th ed.). Pearson Education. pp. 417–438. ISBN 978-0-321-92915-0.
- ↑ Nash, Anthony A.; Dalziel, Robert G.; Fitzgerald, J. Ross (2015). "Mechanisms of Cell and Tissue Damage". Mims' Pathogenesis of Infectious Disease (6th ed.). London: Academic Press. pp. 171–231. ISBN 978-0-12-397188-3.
- ↑ 32.0 32.1 Tortota, Gerard (2013). Microbiology an Introduction. Pearson. ISBN 978-0-321-73360-3.
- ↑ Hosmer, Jennifer; Nasreen, Marufa; Dhouib, Rabeb; Essilfie, Ama-Tawiah; Schirra, Horst Joachim; Henningham, Anna; Fantino, Emmanuelle; Sly, Peter et al. (2022-01-27). "Access to highly specialized growth substrates and production of epithelial immunomodulatory metabolites determine survival of Haemophilus influenzae in human airway epithelial cells" (in en). PLOS Pathogens 18 (1). doi:10.1371/journal.ppat.1010209. ISSN 1553-7374. PMID 35085362.
- ↑ "Pathogen and Biological Contamination Management in Plant Tissue Culture: Phytopathogens, Vitro Pathogens, and Vitro Pests". Plant Cell Culture Protocols. Methods in Molecular Biology. 877. 2012. pp. 57–80. doi:10.1007/978-1-61779-818-4_6. ISBN 978-1-61779-817-7.
- ↑ "Ribosomal crystallography: initiation, peptide bond formation, and amino acid polymerization are hampered by antibiotics". Annu Rev Microbiol 58: 233–51. 2004. doi:10.1146/annurev.micro.58.030603.123822. PMID 15487937.
- ↑ Khachatourians GG (November 1998). "Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria". CMAJ 159 (9): 1129–36. PMID 9835883. PMC 1229782. http://www.cmaj.ca/cgi/pmidlookup?view=reprint&pmid=9835883.
- ↑ Keen, E. C. (2012). "Phage Therapy: Concept to Cure". Frontiers in Microbiology 3: 238. doi:10.3389/fmicb.2012.00238. PMID 22833738.
- ↑ Rutala, William A.; Weber, David J. (November 2023). "Risk of disease transmission to patients from "contaminated" surgical instruments and immediate use steam sterilization". American Journal of Infection Control 51 (11): A72–A81. doi:10.1016/j.ajic.2023.01.019. ISSN 0196-6553. PMID 37890956. https://linkinghub.elsevier.com/retrieve/pii/S0196655323000561.
- ↑ "Use of disinfectants: alcohol and bleach" (in en), Infection Prevention and Control of Epidemic- and Pandemic-Prone Acute Respiratory Infections in Health Care (World Health Organization), 2014, https://www.ncbi.nlm.nih.gov/books/NBK214356/, retrieved 2026-07-11
- ↑ Program, Human Foods (2024-09-05). "Cooking (Food Safety for Moms-to-Be)" (in en). FDA. https://www.fda.gov/food/people-risk-foodborne-illness/cooking-food-safety-moms-be.
- ↑ 41.00 41.01 41.02 41.03 41.04 41.05 41.06 41.07 41.08 41.09 41.10 41.11 41.12 41.13 41.14 41.15 41.16 41.17 Unless else specified in boxes then ref is: Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007). Lippincott's Illustrated Reviews: Microbiology (Lippincott's Illustrated Reviews Series). Hagerstown, MD: Lippincott Williams & Wilkins. pp. 332–353. ISBN 978-0-7817-8215-9.
- ↑ "Comparison of modified Bordet-Gengou and modified Regan-Lowe media for the isolation of Bordetella pertussis and Bordetella parapertussis". J. Clin. Microbiol. 26 (12): 2661–3. 1988. doi:10.1128/JCM.26.12.2661-2663.1988. PMID 2906642.
- ↑ 43.000 43.001 43.002 43.003 43.004 43.005 43.006 43.007 43.008 43.009 43.010 43.011 43.012 43.013 43.014 43.015 43.016 43.017 43.018 43.019 43.020 43.021 43.022 43.023 43.024 43.025 43.026 43.027 43.028 43.029 43.030 43.031 43.032 43.033 43.034 43.035 43.036 43.037 43.038 43.039 43.040 43.041 43.042 43.043 43.044 43.045 43.046 43.047 43.048 43.049 43.050 43.051 43.052 43.053 43.054 43.055 43.056 43.057 43.058 43.059 43.060 43.061 43.062 43.063 43.064 43.065 43.066 43.067 43.068 43.069 43.070 43.071 43.072 43.073 43.074 43.075 43.076 43.077 43.078 43.079 43.080 43.081 43.082 43.083 43.084 43.085 43.086 43.087 43.088 43.089 43.090 43.091 43.092 43.093 43.094 43.095 43.096 43.097 43.098 43.099 43.100 43.101 43.102 43.103 43.104 43.105 43.106 43.107 43.108 43.109 43.110 43.111 43.112 43.113 43.114 43.115 43.116 43.117 43.118 43.119 43.120 43.121 43.122 43.123 43.124 43.125 43.126 43.127 43.128 43.129 43.130 43.131 43.132 43.133 43.134 43.135 43.136 43.137 43.138 43.139 43.140 43.141 43.142 43.143 43.144 43.145 43.146 43.147 43.148 43.149 43.150 43.151 43.152 43.153 43.154 43.155 43.156 43.157 43.158 43.159 43.160 43.161 43.162 43.163 43.164 43.165 43.166 43.167 43.168 43.169 43.170 43.171 43.172 43.173 43.174 43.175 43.176 43.177 43.178 43.179 43.180 43.181 43.182 43.183 43.184 43.185 43.186 43.187 43.188 43.189 43.190 43.191 43.192 43.193 43.194 43.195 43.196 43.197 43.198 43.199 43.200 43.201 43.202 43.203 43.204 43.205 43.206 43.207 43.208 43.209 43.210 43.211 43.212 43.213 43.214 43.215 43.216 43.217 43.218 43.219 43.220 43.221 43.222 43.223 43.224 43.225 43.226 43.227 43.228 43.229 43.230 43.231 43.232 43.233 43.234 43.235 43.236 43.237 43.238 43.239 43.240 43.241 43.242 43.243 43.244 43.245 43.246 43.247 43.248 43.249 43.250 43.251 43.252 43.253 43.254 43.255 43.256 43.257 43.258 43.259 43.260 43.261 43.262 43.263 43.264 43.265 43.266 43.267 43.268 43.269 43.270 43.271 43.272 43.273 43.274 43.275 43.276 43.277 43.278 43.279 43.280 43.281 43.282 43.283 43.284 43.285 43.286 43.287 43.288 43.289 43.290 43.291 43.292 43.293 43.294 43.295 43.296 43.297 43.298 43.299 43.300 43.301 43.302 43.303 Fisher, Bruce; Harvey, Richard P.; Champe, Pamela C. (2007). Lippincott's Illustrated Reviews: Microbiology (Lippincott's Illustrated Reviews Series). Hagerstown, MD: Lippincott Williams & Wilkins. pp. 332–353. ISBN 978-0-7817-8215-9.
- ↑ 44.0 44.1 44.2 "Foodborne Campylobacter: infections, metabolism, pathogenesis and reservoirs". International Journal of Environmental Research and Public Health 10 (12): 6292–304. 2013. doi:10.3390/ijerph10126292. PMID 24287853. Bibcode: 2013IJERP..10.6292E.
- ↑ 45.0 45.1 Bowden GHW (1996). Baron S. ed. Actinomycosis in: Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. (via NCBI Bookshelf). ISBN 978-0-9631172-1-2.
- ↑ Baron, Samuel (1996). Medical Microbiology (4th ed.). University of Texas Medical Branch at Galveston, Galveston, Texas. ISBN 978-0-9631172-1-2.
- ↑ Rollins, David M. (2000). "BSCI424 Laboratory Media". University of Maryland. https://www.life.umd.edu/classroom/bsci424/LabMaterialsMethods/BSCI424Media.htm.
- ↑ Cain, Donna (January 14, 2015). "MacConkey Agar (CCCCD Microbiology". Collin College. http://iws2.collin.edu/dcain/CCCCD%20Micro/macconkeyagar.htm.
- ↑ "Chocolate agar, a differential medium for gram-positive cocci". Journal of Clinical Microbiology 20 (4): 822–3. 1984. doi:10.1128/JCM.20.4.822-823.1984. PMID 6490866.
- ↑ "Growth of Helicobacter pylori in various liquid and plating media". Lett. Appl. Microbiol. 30 (3): 192–6. 2000. doi:10.1046/j.1472-765x.2000.00699.x. PMID 10747249.
- ↑ "Differentiation of Pathogenic and Saprophytic Leptospires I. Growth at Low Temperatures". J. Bacteriol. 94 (1): 27–31. 1967. doi:10.1128/JB.94.1.27-31.1967. PMID 6027998. Bibcode: 1967JBact..94...27J.
- ↑ "Thayer Martin Agar (Modified) Procedure". University of Nebraska Medical Center, Clinical Laboratory Science Program. https://webmedia.unmc.edu/alliedhealth/CLS/CLS418%2008/Thayer%20Martin%20Agar%20Procedure%2008.pdf.
- ↑ Allen, Mary E. (2005). "MacConkey Agar Plates Protocols". American Society for Microbiology. http://www.microbelibrary.org/component/resource/laboratory-test/2855-macconkey-agar-plates-protocols. Created: 30 September 2005. Last update: 01 April 2013
- ↑ "Hektoen Enteric Agar". Austin Community College District. http://www.austincc.edu/microbugz/hektoen_enteric_agar.php.
- ↑ "Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants". Lancet 2 (8605): 240–5. 1988. doi:10.1016/s0140-6736(88)92536-6. PMID 2899235.
- ↑ Pfeffer, C.; Oliver, J.D. (2003). "A comparison of thiosulphate-citrate-bile salts-sucrose (TCBS) agar and thiosulphate-chloride-iodide (TCI) agar for the isolation of Vibrio species from estuarine environments". Letters in Applied Microbiology 36 (3): 150–151. doi:10.1046/j.1472-765X.2003.01280.x. PMID 12581373. Bibcode: 2003LAppM..36..150P.
- ↑ "Yersinia pestis". Wadsworth Center. 2006. http://www.health.ny.gov/guidance/oph/wadsworth/yersinia_pestis.pdf.
- ↑ 58.000 58.001 58.002 58.003 58.004 58.005 58.006 58.007 58.008 58.009 58.010 58.011 58.012 58.013 58.014 58.015 58.016 58.017 58.018 58.019 58.020 58.021 58.022 58.023 58.024 58.025 58.026 58.027 58.028 58.029 58.030 58.031 58.032 58.033 58.034 58.035 58.036 58.037 58.038 58.039 58.040 58.041 58.042 58.043 58.044 58.045 58.046 58.047 58.048 58.049 58.050 58.051 58.052 58.053 58.054 58.055 58.056 58.057 58.058 58.059 58.060 58.061 58.062 58.063 58.064 58.065 58.066 58.067 58.068 58.069 58.070 58.071 58.072 58.073 58.074 58.075 58.076 58.077 58.078 58.079 58.080 58.081 58.082 58.083 58.084 58.085 58.086 58.087 58.088 58.089 58.090 58.091 58.092 58.093 58.094 58.095 58.096 58.097 58.098 58.099 58.100 58.101 58.102 58.103 58.104 58.105 58.106 58.107 58.108 58.109 58.110 58.111 58.112 58.113 58.114 58.115 58.116 58.117 58.118 58.119 58.120 58.121 58.122 58.123 58.124 58.125 58.126 58.127 58.128 58.129 58.130 58.131 58.132 58.133 58.134 58.135 58.136 58.137 58.138 58.139 58.140 58.141 58.142 58.143 58.144 58.145 58.146 58.147 58.148 58.149 58.150 58.151 58.152 58.153 58.154 58.155 58.156 58.157 58.158 58.159 58.160 58.161 58.162 58.163 58.164 58.165 58.166 58.167 58.168 58.169 58.170 58.171 58.172 58.173 58.174 58.175 58.176 58.177 58.178 58.179 58.180 58.181 58.182 58.183 58.184 58.185 58.186 58.187 58.188 58.189 58.190 58.191 58.192 58.193 58.194 58.195 58.196 58.197 58.198 58.199 58.200 58.201 58.202 58.203 58.204 58.205 58.206 58.207 58.208 58.209 58.210 58.211 58.212 58.213 58.214 "Bacteria Table". Creighton University School of Medicine. http://medschool.creighton.edu/fileadmin/user/medicine/MMI/Files/Bacteria_Table.pdf.
- ↑ Brook, I (Oct 2008). "Actinomycosis: diagnosis and management.". Southern Medical Journal 101 (10): 1019–23. doi:10.1097/SMJ.0b013e3181864c1f. PMID 18791528.
- ↑ Mabeza, GF; Macfarlane J (March 2003). "Pulmonary actinomycosis". European Respiratory Journal 21 (3): 545–551. doi:10.1183/09031936.03.00089103. PMID 12662015.
- ↑ "Anthrax in animals". Food and Agriculture Organization. 2001. http://www.fao.org/ag/magazine/0112sp.htm.
- ↑ "CDC Anthrax Q & A: Treatment". http://emergency.cdc.gov/agent/anthrax/faq/treatment.asp.
- ↑ "FDA approves raxibacumab to treat inhalational anthrax". https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332341.htm.
- ↑ 64.0 64.1 Itzhak Brook (Jan 28, 2014). "Bacteroides Infection Follow-up". Medscape. http://emedicine.medscape.com/article/233339-followup.
- ↑ "Clinical practice. Lyme disease". The New England Journal of Medicine 370 (18): 1724–31. 2014. doi:10.1056/NEJMcp1314325. PMID 24785207.
- ↑ 66.0 66.1 "Clinical Manifestations and Treatment of Lyme Disease". Clinics in Laboratory Medicine 35 (4): 765–78. 2015. doi:10.1016/j.cll.2015.08.004. PMID 26593256.
- ↑ "Nervous System Lyme Disease". Clinics in Laboratory Medicine 35 (4): 779–95. 2015. doi:10.1016/j.cll.2015.07.002. PMID 26593257.
- ↑ 68.0 68.1 68.2 68.3 68.4 68.5 Barbour, Alan G. (2017). "Relapsing Fever". in Kasper, Dennis L.; Fauci, Anthony S.. Harrison's Infectious Diseases (3rd ed.). New York: McGraw Hill Education. pp. 678–687. ISBN 978-1-259-83597-1.
- ↑ "Relapsing Fever Borreliae: A Global Review". Clinics in Laboratory Medicine 35 (4): 847–65. 2015. doi:10.1016/j.cll.2015.07.001. PMID 26593261.
- ↑ Atkinson, William (May 2012). Tetanus Epidemiology and Prevention of Vaccine-Preventable Diseases (12 ed.). Public Health Foundation. pp. 291–300. ISBN 978-0-9832631-3-5. https://www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html. Retrieved 12 February 2015.
- ↑ "Diphtheria vaccine". Wkly Epidemiol Rec 81 (3): 24–32. 20 January 2006. PMID 16671240. https://bojadla.edu.pl/b/wer8103.pdf.
- ↑ "ESCHERICHIA COLI". Public Health Agency of Canada. 2012-04-30. http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/escherichia-coli-eng.php.
- ↑ 73.0 73.1 "Signs & Symptoms". 13 December 2018. https://www.cdc.gov/tularemia/signssymptoms/. Page last reviewed: October 26, 2015
- ↑ Ryan, KJ; Ray, CG, eds (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. ISBN 978-0-8385-8529-0.
- ↑ "Klebsiella pneumoniae in Healthcare Settings". Centers for Disease Control and Prevention. 19 February 2021. https://www.cdc.gov/HAI/organisms/klebsiella/klebsiella.html. Page last reviewed: November 24, 2010. Page last updated: August 27, 2012
- ↑ Slack, A (Jul 2010). "Leptospirosis.". Australian Family Physician 39 (7): 495–8. PMID 20628664.
- ↑ McBride, AJ; Athanazio, DA; Reis, MG; Ko, AI (Oct 2005). "Leptospirosis". Current Opinion in Infectious Diseases 18 (5): 376–86. doi:10.1097/01.qco.0000178824.05715.2c. PMID 16148523.
- ↑ 78.0 78.1 Hartskeerl, Rudy A.; Wagenaar, Jiri F.P. (2017). "Leptospirosis". in Kasper, Dennis L.; Fauci, Anthony S.. Harrison's Infectious Diseases. New York: McGraw Hill Education. pp. 672–678. ISBN 978-1-259-83597-1.
- ↑ "Leprosy Fact sheet N°101". World Health Organization. January 2014. https://www.who.int/mediacentre/factsheets/fs101/en/.
- ↑ "Tuberculosis Fact sheet N°104". October 2015. https://www.who.int/mediacentre/factsheets/fs104/en/.
- ↑ Institut Pasteur Press Office - Vaccine against shigellosis (bacillary dysentery):a promising clinical trial 15 January 2009. Retrieved on 27 February 2009
- ↑ Levinson, W. (2010). Review of Medical Microbiology and Immunology (11th ed.). pp. 94–9.
- ↑ "Syphilis - CDC Fact Sheet (Detailed)". November 2, 2015. https://www.cdc.gov/std/syphilis/stdfact-syphilis-detailed.htm.
- ↑ "Reexamining syphilis: an update on epidemiology, clinical manifestations, and management". Annals of Pharmacotherapy 42 (2): 226–36. February 2008. doi:10.1345/aph.1K086. PMID 18212261.
- ↑ "Syphilis". Lancet 389 (10078): 1550–1557. 2017. doi:10.1016/S0140-6736(16)32411-4. PMID 27993382.
- ↑ "Molecular and physiological insights into plague transmission, virulence and etiology". Microbes Infect. 8 (1): 273–84. 2006. doi:10.1016/j.micinf.2005.06.006. PMID 16182593.
- ↑ Wagle PM. (1948). "Recent advances in the treatment of bubonic plague". Indian J Med Sci 2: 489–94.
- ↑ Meyer KF. (1950). "Modern therapy of plague". JAMA 144 (12): 982–5. doi:10.1001/jama.1950.02920120006003. PMID 14774219.
- ↑ "A decade of plague epidemiology and control in the Western Usambara mountains, north-east Tanzania". Acta Tropica 50 (4): 323–9. 1992. doi:10.1016/0001-706X(92)90067-8. PMID 1356303.
- ↑ "Yersinia pestis CO92ΔyopH Is a Potent Live, Attenuated Plague Vaccine". Clin. Vaccine Immunol. 14 (9): 1235–8. September 2007. doi:10.1128/CVI.00137-07. PMID 17652523.
External links
| Classification |
|---|
- Bacterial Pathogen Pronunciation by Neal R. Chamberlain, Ph.D. at A.T. Still University
- Pathogenic bacteria genomes and related information at PATRIC, a Bioinformatics Resource Center funded by NIAID
